Hormone-related headache

Medical Clinics of North America

Volumn 85, Issue 4, 2001, Pages 1017-1035

  Silberstein, Stephen D ^b  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

DIHYDROERGOTAMINE; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; ORAL CONTRACEPTIVE AGENT; PROGESTERONE; SEROTONIN AGONIST; SEX HORMONE;

ESTROGEN THERAPY; FIRST TRIMESTER PREGNANCY; HEADACHE; HORMONE ACTION; HUMAN; MENOPAUSE; MENSTRUAL CYCLE; MIGRAINE; PRIORITY JOURNAL; REVIEW;

EID: 0034912817     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(05)70357-6     Document Type: Article

References (110)

1. Pathophysiology of dysmenorrhea
2. Can one cure migraine in women by inducing menopause? Report on forty-two cases
3. Treatment of premenstrual syndrome with bromocriptine
4. Effect of bromocriptine on the premenstrual syndrome: A double-blind clinical trial
5. Transdermal estrogen
6. An evaluation of clinical response to piperazine estrone sulphate ("Harmogen") in menopausal patients
7. Hormonal contraception
8. Migraine in the reproductive cycle
9. Danazol and migraine
10. Double-blind psychometric studies on the effects of natural estrogens on postmenopausal women
11. Migraine and oral contraception
12. The effect of hysterectomy and bilateral oophorectomy in women with severe premenstrual syndrome
13. Lasting response to ovariectomy in severe intractable premenstrual syndrome
14. Nonoral routes of estrogen administration
15. Prostaglandins and nonsteroidal antiinflammatory drugs in dysmenorrhea
16. Oral contraceptives and stroke in young women
17. Gonadotropin-releasing hormone and its analogues
18. Double-blind cross-over study of estrogen replacement therapy
19. Mood changes and menstrual symptoms with different gestagen/estrogen combinations: A double-blind comparison with a placebo
20. Sex-hormone related events in migrainous females: A clinical comparative study between migraine with aura and migraine without aura
21. Migraine and oral contraceptives
22. Prevention of menstrual migraine by percutaneous estradiol
23. Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women
24. Headache and sex hormone therapy
25. Menstrual migraine: Differential diagnosis, evaluation and treatment
26. Migraine and reproductive hormones throughout the menstrual cycle
27. The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine
28. Ineffectiveness of progesterone suppository treatment for premenstrual syndrome
29. A placebo-controlled double-blind cross-over investigation of the side effects attributed to oral contraceptives
30. Hormone replacement therapy and endometrial cancer risk: A metaanalysis
31. Hormone therapy to prevent disease and prolong life in postmenopausal women
32. The use of androgens in the menopause and other gynecic disorders
33. No effect of vitamin B-6 against premenstrual tension: A controlled clinical study
34. Induced anovulation as a treatment of premenstrual tension syndrome: A double-blind cross-over study with GnRH-agonist versus placebo
35. Oral contraception and stroke: Evidence from the Royal College of General Practitioners' Oral Contraception study
36. Classification and diagnostic criteria for headache disorders, cranial neuralgia, and facial pain
37. Continuous bromocriptine therapy in menstrual migraine
38. Dysmenorrhea induced by autologous transfusion
39. Relationship of headache to phase of the menstrual cycle among young women: A daily diary study
40. Efficacy of transdermal estradiol
41. Deterioration or onset of migraine under estrogen replacement therapy in the menopause
42. Group and menstrual phase effect in reported headaches among college students
43. The relationship of headache frequency to hormone use in migraine
44. Headache and treatment with oral contraceptives
45. The confirmation of a biochemical marker for women's hormonal migraine: The depo-estradiol challenge test
46. Oral contraception and risk of a cerebral thromboembolic attack: Results of a case-control study
47. Clinical efficacy of 2.5 and 5 mg Zolmitriptan (Zomig) in migraine associated with menses or in patients using nonprogestogen oral contraceptives
48. Two-year prospective study in Columbia of Norplant implants
49. Endocrine headaches
50. Migraine and menstruation
51. Treatment of the premenstrual syndrome by subcutaneous estradiol implants and cyclical oral noresthisterone: Placebo controlled study
52. Postmenopausal hormone replacement therapy
53. Graded sequential therapy in the menopause: A double-blind study
54. Menopause: Endocrinology, consequences of estrogen deficiency, effects of hormonal replacement therapy, treatment regimens
55. Prostaglandins, prostacyclin, thromboxane A2, and leukotrienes
56. Premenstrual syndrome - Pathophysiologic considerations
57. The neurobiology of vascular head pain
58. The premenstrual syndrome: Effects of "medical ovariectomy"
59. Menstrual headache
60. Relevance of prostaglandins in true menstrual migraine
61. Characteristics of headache at menopause: A clinico-epidemiologic study
62. A pilot study of oral sumatriptan as intermittent prophylaxis of menstruation-related migraine
63. Naratriptan as short-term prophylaxis of menstrually-associated migraine: A randomized, double-blind, placebo-controlled study
64. Clinical studies on oral contraceptives: A randomized, double-blind, cross-over study of four different preparations (Anovlar mite, Lyndiol mite, Ovulen, and Volidan)
65. Stroke in users of low-dose oral contraceptives
66. Oral contraceptive drugs and migraine
67. GnRH agonists and add-back therapy: Is there a perfect combination?
68. Oral contraceptives and nonfatal vascular disease
69. Physiology and treatment of hot flushes
70. Premenstrual syndrome
71. A controlled study of the effect of oral contraceptives on migraine
72. Observation on 500 cases of migraine and allied vascular headaches
73. Estrogen treatment of postmenopausal women
74. The menstrual cycle: A double-blind study of symptoms, mood and behavior, and biochemical variables using enovid and placebo
75. Menstrual migraine
76. DHE-45 in the prophylaxis of menstrually related migraine
77. Migraine and pregnancy
78. Rizatriptan in the treatment of menstrual migraine
79. Estrogens, progestins, and headache
80. Sex hormones and headache
81. Migraine: Diagnosis and treatment
82. Sumatriptan tablets and injection are effective in the treatment of menstrually associated migraine: A review
83. The symptomatology of progestogen intolerance
84. Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan
85. Menstrual migraine headache: Results of a controlled, experimental, outcome study of nondrug treatments
86. The role of estradiol withdrawal in the etiology of menstrual migraine
87. Estrogen-withdrawal migraine: I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration
88. The role of progesterone in menstrual migraine
89. Menstrual cycle and headache in a population-based sample of migraineurs: Results from a diary study
90. Extending the duration of active oral contraceptive pills to manage hormone withdrawal symptoms
91. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease
92. The combination of depot gonadotrophin releasing hormone agonist and cyclical hormone replacement therapy for dysfunctional uterine bleeding
93. Migraine and risk of ischemic stroke: A case-control study
94. Case-control study of migraine and risk of ischemic stroke in young women
95. Vital statistics of the United States
96. Estrogen, headache and oral contraceptives
97. The fate of the untreated menopause
98. Epidemiology of headache and migraine in women
99. Treatment of severe premenstrual syndrome with estradiol patches and cyclical oral norethisterone
100. The effect of oral contraceptives on migraine
101. Controlled trial of pyridoxine in the premenstrual syndrome
102. A profile of menstrual migraine sufferers
103. Estrogen therapy in postmenopausal women: Effects on cognitive function and dementia
104. Bromocriptine and noresthisterone in the treatment of premenstrual syndrome